You are here

Articles

Template letter to your MP regarding NICE appraisal of Dasatinb and Nilotinib

published: 8 November 2007

Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia

published: 7 November 2007

ENACT - AMN 107 Trials. Click here to view list of centres open and recruiting.

published: 8 October 2007

EMEA approval of Tasigna expected by November 2007

published: 29 September 2007

EMEA approve 100mg as recommended starting dose of Sprycel for chronic phase CML

published: 29 September 2007

EU Health Portal Multilingual Newsletter.

published: 13 September 2007

Chronic Myeloid Leukaemia as a Model of Disease Evolution in Human Cancer. Junia V. Melo; David J. Barnes. 08/31/2007

published: 13 September 2007

SMC recommends restricted use of Dasatinib/Sprycel

published: 9 May 2007

Second generation inhibitors of BCR ABL for the treatment of IM resistant CML

published: 25 April 2007

Therapeutics Targets in CML - Nicholas B Heaney and Tessa L Hollyoake

published: 25 April 2007

Summary of CML Seminar held in Manchester in October 2006

published: 10 December 2006

Warsaw Declaration

published: 25 September 2006

And then there was Glivec

published: 19 September 2006

Understanding Leukemia and Lymphoma

published: 9 September 2006

Wikipedia's CML entry.

published: 22 July 2006